These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2563926)

  • 1. H2 antagonists in the treatment of reflux esophagitis: a critical analysis.
    Stalnikowicz-Darvasi R
    Am J Gastroenterol; 1989 Mar; 84(3):245-8. PubMed ID: 2563926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials.
    Koelz HR
    Scand J Gastroenterol Suppl; 1989; 156():25-36. PubMed ID: 2568015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of nizatidine and famotidine for maintenance therapy of erosive esophagitis.
    Hamamoto N; Hashimoto T; Adachi K; Hirakawa K; Ishihara S; Inoue H; Taniura H; Niigaki M; Sato S; Kushiyama Y; Suetsugu H; Miyake T; Kinoshita Y
    J Gastroenterol Hepatol; 2005 Feb; 20(2):281-6. PubMed ID: 15683433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
    Pfefferkorn MD; Croffie JM; Gupta SK; Molleston JP; Eckert GJ; Corkins MR; Fitzgerald JF
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic approaches to healing esophagitis.
    Boyce HW
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):22S-27S; discussion 27S-29S. PubMed ID: 9127623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
    McKenna CJ; Mills JG; Goodwin C; Wood JR
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reflux esophagitis. Step-down instead of step-up].
    MMW Fortschr Med; 2006 Nov; 148(47):56-7. PubMed ID: 17168191
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of reflux esophagitis with histamine H2-receptor antagonists.
    Kishi S; Tsuzi Y; Matsumura M; Kakutani A; Ito S; Mori H
    Tokushima J Exp Med; 1985 Dec; 32(3-4):65-70. PubMed ID: 2875547
    [No Abstract]   [Full Text] [Related]  

  • 10. [Our experience in the treatment of reflux esophagitis with histamine H2 receptor antagonists].
    Cappelli J; Morobe J; Van Laethem A; Musin L
    Acta Chir Belg; 1983; 83(6):440-3. PubMed ID: 6318487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
    Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of gastrosidine (famotidine) in the treatment of gastroesophageal reflux at the reflux esophagitis stage].
    Vasil'ev IuV; Li IA
    Eksp Klin Gastroenterol; 2002; (4):30-3, 131. PubMed ID: 12503271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [H2-blockers in reflux-esophagitis].
    Berstad A
    Tidsskr Nor Laegeforen; 1983 Jul; 103(19-21):1439-41. PubMed ID: 6138879
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of ranitidine in the treatment of gastroesophageal reflux and its complications].
    Mainguet P
    Rev Med Suisse Romande; 1995 Oct; 115(10):781-8. PubMed ID: 7501930
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of symptoms of gastroesophageal reflux disease: does endoscopy influence medical management?
    Ellis KK; Oehlke M; Helfand M; Lieberman D
    Am J Gastroenterol; 1997 Sep; 92(9):1472-4. PubMed ID: 9317065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of oxmetidine and ranitidine on reflux behavior in patients with esophagitis].
    Weiser HF; Gubernatis G; Siewert JR
    Z Gastroenterol; 1983 Oct; 21(10):580-4. PubMed ID: 6139923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA; Kuppermann M; Richter JE
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conservative treatment of reflux disease of the esophagus--pro].
    Witzel L; Peerenboom H
    Z Gastroenterol; 1985 Dec; 23(12):655-7. PubMed ID: 2868580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.